COMPARATIVE EVALUATION OF INTRAVITREAL DICLOFENAC PLUS BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF NAÏVE DIABETIC MACULAR EDEMA

owshera Medical College/ Qazi Hussain Ahmad Medical Complex0 个研究点目标入组 40 人开始时间: 待定最近更新: 2022年6月27日

试验速览

暂无简介。

•The ‘ETDRS’ criteria was utilized for enrollment of treatment naïve eyes of DME, defined as any hard exudates/dot blot hemorrhages, retinal thickening/edema within 500µm from the center of the fovea or involving the very center, examined clinically on fundoscopy
•Age range from 45 years to 78 years

•Any history of prior retinal laser therapy
•History of prior intravitreal injections any type
•Any intra-ocular procedure done within last 6 months
•Rubeosis irides
•Any glaucomatous eye damage
•evidence of ischemic maculopathy, defined as an enlarged foveal avascular zone (FAZ) = 1500µm;
•Best corrected VA of = 6/12 or = 6/120
•Significant media opacity precluding fundus view
•Associated morbid conditions like, monocularity, pregnancy, diabetic nephropathy grade 3 and HbA1c = 10.

发起方

owshera Medical College/ Qazi Hussain Ahmad Medical Complex